Senior insider sale
Chief Medical Officer at NUVALENT, INC. — senior position signals high conviction
$723.8K
7.42K shares
What this filing means
TURNER CHRISTOPHER DURANT plans to sell 7.42K shares of NUVALENT, INC. valued at approximately $723.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001193125-26-003151
Officer· Chief Medical Officer
Since Jul 2021
7.42K
Shares to sell
$723.8K
Approx. market value
7.42K
Acquired (3 months)
2
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit Vesting
Equity Compensation
1/6/2026
3.18KRestricted Stock Unit Vesting
Equity Compensation
1/5/2026
4.24KTotal acquired7.42K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/6/2026 | Restricted Stock Unit Vesting Equity Compensation | 3.18K | — |
1/5/2026 | Restricted Stock Unit Vesting Equity Compensation | 4.24K | — |
| Total | 7.42K | ||
Planned & Completed Dispositions2
NASDAQPlanned
Units to sell
3.18K
Market value
$311.5K
1/6/2026
NASDAQPlanned
Units to sell
4.24K
Market value
$412.2K
1/5/2026
Total
Units
7.42K
Value
$723.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/6/2026 | 3.18K | $311.5K | NASDAQ | Planned |
1/5/2026 | 4.24K | $412.2K | NASDAQ | Planned |
| Total | 7.42K | $723.8K | ||